Australija - engleski - Department of Health (Therapeutic Goods Administration)

b braun australia pty ltd - propofol, quantity: 10 mg/ml - injection, intravenous infusion - excipient ingredients: glycerol; medium chain triglycerides; soya oil; egg lecithin; sodium oleate; water for injections - induction of general anaesthesia in children and adults propofol-lipuro 1% is a short-acting intravenous anaesthetic agent suitable for induction of general anaesthesia in adults and children aged one month and older. maintenance of general anaesthesia in children and adults propofol-lipuro 1% is a short-acting intravenous anaesthetic agent suitable for maintenance of general anaesthesia in adults and children aged 3 years and older. propofol-lipuro 1% may also be used for maintenance of general anaesthesia in children aged from one month to 3 years for procedures not exceeding 60 minutes, unless alternative anaesthetic agents should be avoided. propofol-lipuro has no analgesic properties. sedation during intensive care in adults propofol-lipuro 1% may be used in adults for sedation of ventilated patients receiving intensive care. conscious sedation for surgical and diagnostic procedures in adults propofol-lipuro 1% may also be used in adults for monitored conscious sedation for surgical and diagnostic procedures.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - propofol, quantity: 1000 mg - injection, emulsion - excipient ingredients: egg lecithin; soya oil; sodium oleate; water for injections; sodium hydroxide; glycerol - short acting intravenous anaesthetic agent suitable for induction and maintenance of general anaesthesia in adults and children aged three years and older. provive 1% has no analgesic properties. although the safety and efficacy of propofol in paediatric day surgery have not been demonstrated, it may also be a useful agent in this setting and its use should not be precluded. provive 1% may also be used in adults for sedation of ventilated patients receiving intensive care. provive 1% may also be used in adults for monitored conscious sedation and diagnostic procedures.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - propofol, quantity: 500 mg - injection, emulsion - excipient ingredients: soya oil; water for injections; egg lecithin; sodium oleate; glycerol; sodium hydroxide - short acting intravenous anaesthetic agent suitable for induction and maintenance of general anaesthesia in adults and children aged three years and older. provive 1% has no analgesic properties. although the safety and efficacy of propofol in paediatric day surgery have not been demonstrated, it may also be a useful agent in this setting and its use should not be precluded. provive 1% may also be used in adults for sedation of ventilated patients receiving intensive care. provive 1% may also be used in adults for monitored conscious sedation and diagnostic procedures.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - propofol, quantity: 200 mg - injection, emulsion - excipient ingredients: sodium oleate; egg lecithin; glycerol; water for injections; soya oil; sodium hydroxide - short acting intravenous anaesthetic agent suitable for induction and maintenance of general anaesthesia in adults and children aged three years and older. provive 1% has no analgesic properties. although the safety and efficacy of propofol in paediatric day surgery have not been demonstrated, it may also be a useful agent in this setting and its use should not be precluded. provive 1% may also be used in adults for sedation of ventilated patients receiving intensive care. provive 1% may also be used in adults for monitored conscious sedation and diagnostic procedures.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - propofol, quantity: 10 mg/ml - injection, emulsion - excipient ingredients: glycerol; oleic acid; soya oil; sodium hydroxide; egg lecithin; water for injections - fresofol 1% is a short-acting intravenous anaesthetic agent suitable for the induction and maintenance of general anaesthesia in adults and children aged three years and older. fresofol 1% has no analgesic properties. although the safety and efficacy of fresofol 1% in paediatric day surgery have not been demonstrated, it may be a useful agent in this setting and its use should not be precluded. fresofol 1% may also be used in adults for the sedation of ventilated patients receiving intensive care, and for monitored conscious sedation for surgical and diagnostic procedures.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - propofol, quantity: 10 mg/ml - injection, emulsion - excipient ingredients: soya oil; water for injections; egg lecithin; sodium hydroxide; oleic acid; glycerol - fresofol 1% is a short-acting intravenous anaesthetic agent suitable for the induction and maintenance of general anaesthesia in adults and children aged three years and older. fresofol 1% has no analgesic properties. although the safety and efficacy of fresofol 1% in paediatric day surgery have not been demonstrated, it may be a useful agent in this setting and its use should not be precluded. fresofol 1% may also be used in adults for the sedation of ventilated patients receiving intensive care, and for monitored conscious sedation for surgical and diagnostic procedures.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - propofol, quantity: 10 mg/ml - injection, emulsion - excipient ingredients: soya oil; glycerol; oleic acid; sodium hydroxide; water for injections; egg lecithin - fresofol 1% is a short-acting intravenous anaesthetic agent suitable for the induction and maintenance of general anaesthesia in adults and children aged three years and older. fresofol 1% has no analgesic properties. although the safety and efficacy of fresofol 1% in paediatric day surgery have not been demonstrated, it may be a useful agent in this setting and its use should not be precluded. fresofol 1% may also be used in adults for the sedation of ventilated patients receiving intensive care, and for monitored conscious sedation for surgical and diagnostic procedures.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - lidocaine hydrochloride, quantity: 20 mg/ml; adrenaline (epinephrine) acid tartrate, quantity: 22.7 microgram/ml (equivalent: adrenaline (epinephrine), qty microgram/ml) - injection, solution - excipient ingredients: sodium metabisulfite; water for injections; sodium chloride; hydrochloric acid; sodium hydroxide - xylocaine solutions are indicated for the production of local or regional anaesthesia by the following techniques: infiltration, intravenous regional anaesthesia - excluding solutions with adrenaline, peripheral nerve block such as intercostal block, major plexus block such as brachial plexus block, epidural block, subarachnoid block.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

specialites septodont pty ltd - lidocaine hydrochloride monohydrate, quantity: 20 mg/ml; adrenaline (epinephrine), quantity: 12.5 microgram/ml (equivalent: adrenaline (epinephrine) acid tartrate, qty 22.8 microgram/ml) - injection, solution - excipient ingredients: sodium chloride; potassium metabisulfite; disodium edetate; sodium hydroxide; water for injections - indications as at 17 july 2003: lignocaine solutions are indicated for the production of local anaesthesia in routine dental procedures and oral surgery by means of infiltration and nerve block techniques. lignocaine solutions with adrenaline are recommended for oral surgery requiring prolonged duration of anaesthesia and haemostasis.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

specialites septodont pty ltd - lidocaine hydrochloride monohydrate, quantity: 20 mg/ml; adrenaline (epinephrine), quantity: 12.5 microgram/ml (equivalent: adrenaline (epinephrine) acid tartrate, qty 22.8 microgram/ml) - injection, solution - excipient ingredients: sodium chloride; potassium metabisulfite; disodium edetate; water for injections; sodium hydroxide - indications as at 17 july 2003: lignocaine solutions are indicated for the production of local anaesthesia in routine procedures and oral surgery by means of infiltration and nerve block techniques. lignocaine solutions with adrenaline are recommended for oral surgery requiring prolonged duration of anaesthesia and haemostasis.